CRISPR News and Research

Latest CRISPR News and Research

A digital CRISPR-based method for quick detection and absolute quantification of SARS-CoV-2

In a recent medRxiv* preprint manuscript, researchers from Singapore and the United States report the development of a digital CRISPR method for the sensitive, specific, and rapid detection of viral nucleic acids at a constant temperature, which could be exploited for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

5 Nov 2020

Researchers solve longstanding mystery about peculiar hybrid structures found in bacteria

Peculiar hybrid structures called retrons that are half RNA, half single-strand DNA are found in many species of bacteria.

5 Nov 2020

Stanford researchers create a highly automated device that can detect COVID-19 in 30 minutes

Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.

5 Nov 2020

New, effective CRISPR-based gene drive approach to control transmission of malaria parasites

Employing a strategy known as "population modification," which involves using a CRISPR-Cas9 gene drive system to introduce genes preventing parasite transmission into mosquito chromosomes, University of California researchers have made a major advance in the use of genetic technologies to control the transmission of malaria parasites.

3 Nov 2020

Machine-learning algorithm helps sort out huge amounts of data for protein research

Sorting huge amounts of data is a bottleneck in protein research, a field that is crucial to make use of the gene-editing technology CRISPR and fully understand diseases like cancer, Alzheimer's and Parkinson's

3 Nov 2020

Andrew Alliance Webinar: Improving reproducibility of large-scale experiments by using a pipette+ system

Karsten Krey, a researcher in the group of Prof Andreas Pichlmair, will present this study, supported by technical data.

3 Nov 2020

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

By exploiting type 1 interferon's ability to foster an antagonistic cellular environment for viral replication, a research group from France pinpointed DEAD-box RNA helicase DDX42 as an intrinsic inhibitor of HIV, but also other pathogenic viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Chikungunya virus.

29 Oct 2020

Tumor suppressor gene represses 'jumping genes'

About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, or "jumping genes," from hopping around the human genome.

29 Oct 2020

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

By leveraging nucleotide triphosphate analog-induced cell death, Chinese researchers unveiled genes that affect the import, export, and metabolism of pervasively used antiviral drugs in the treatment of coronavirus disease (COVID-19). This exciting study is currently available on the bioRxiv* preprint server.

28 Oct 2020

Penn researchers awarded $5.4 million to find genetic risk markers for testicular cancer

The international hunt to find more genetic risk markers for testicular cancer is expanding. A team of researchers led by Katherine L. Nathanson, MD, deputy director of the Abramson Cancer Center and the Pearl Basser Professor for BRCA-Related Research in the Perelman School of Medicine at the University of Pennsylvania, was recently awarded $5.4 million over five years from the National Institutes of Health to continue the long-standing genomics work of the TEsticular CAncer Consortium (TECAC).

28 Oct 2020

Scientists identify new therapeutic targets for SARS-CoV-2

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.

27 Oct 2020

Research findings could potentially help exploit the weaknesses of cancer cells

Every cell in our body constantly divides to form new cells. This happens without us even thinking about it. However, every single time a cell divides, a complicated process has to unfold just the right way for our cells to avoid sickness and death.

22 Oct 2020

Congress should clarify limits of gene-editing technologies, says law professor

Genome editing of human embryos represents one of the most contentious potential scientific applications today. But what if geneticists could sidestep the controversy by editing sperm and eggs instead?

22 Oct 2020

New DNA-cutting tool could advance gene editing for novel treatments

Gene editing for the development of new treatments, and for studying disease as well as normal function in humans and other organisms, may advance more quickly with a new tool for cutting larger pieces of DNA out of a cell's genome, according to a new study by UC San Francisco scientists.

21 Oct 2020

Study helps restore retinal and visual functions of mice models of inherited retinal disease

A breakthrough study, led by researchers from the University of California, Irvine, results in the restoration of retinal and visual functions of mice models suffering from inherited retinal disease.

20 Oct 2020

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.

16 Oct 2020

CRISPR News and Research

Latest CRISPR News and Research

A digital CRISPR-based method for quick detection and absolute quantification of SARS-CoV-2

Researchers solve longstanding mystery about peculiar hybrid structures found in bacteria

Stanford researchers create a highly automated device that can detect COVID-19 in 30 minutes

New, effective CRISPR-based gene drive approach to control transmission of malaria parasites

Machine-learning algorithm helps sort out huge amounts of data for protein research

Andrew Alliance Webinar: Improving reproducibility of large-scale experiments by using a pipette+ system

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Tumor suppressor gene represses 'jumping genes'

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Penn researchers awarded $5.4 million to find genetic risk markers for testicular cancer

Scientists identify new therapeutic targets for SARS-CoV-2

Research findings could potentially help exploit the weaknesses of cancer cells

Congress should clarify limits of gene-editing technologies, says law professor

New DNA-cutting tool could advance gene editing for novel treatments

Study helps restore retinal and visual functions of mice models of inherited retinal disease

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

NIH grants 4D Nucleome award to support research by Gladstone scientists

G protein-coupled receptors help humans taste, smell, and regulate mood and immunity

New quality control system in protein production assembly can shed light on neurogenerative disease

Researchers apply CRISPR technology to eliminate fusion genes present in tumor cells

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey